A system model of the effects of exercise on plasma Interleukin-6 dynamics in healthy individuals: Role of skeletal muscle and adipose tissue

Interleukin-6 (IL-6) has been recently shown to play a central role in glucose homeostasis, since it stimulates the production and secretion of Glucagon-like Peptide-1 (GLP-1) from intestinal L-cells and pancreas, leading to an enhanced insulin response. In resting conditions, IL-6 is mainly produced by the adipose tissue whereas, during exercise, skeletal muscle contractions stimulate a marked IL-6 secretion as well. Available mathematical models describing the effects of exercise on glucose homeostasis, however, do not account for this IL-6 contribution. This study aimed at developing and validating a system model of exercise’s effects on plasma IL-6 dynamics in healthy humans, combining the contributions of both adipose tissue and skeletal muscle. A two-compartment description was adopted to model plasma IL-6 changes in response to oxygen uptake’s variation during an exercise bout. The free parameters of the model were estimated by means of a cross-validation procedure performed on four different datasets. A low coefficient of variation (<10%) was found for each parameter and the physiologically meaningful parameters were all consistent with literature data. Moreover, plasma IL-6 dynamics during exercise and post-exercise were consistent with literature data from exercise protocols differing in intensity, duration and modality. The model successfully emulated the physiological effects of exercise on plasma IL-6 levels and provided a reliable description of the role of skeletal muscle and adipose tissue on the dynamics of plasma IL-6. The system model here proposed is suitable to simulate IL-6 response to different exercise modalities. Its future integration with existing models of GLP-1-induced insulin secretion might provide a more reliable description of exercise’s effects on glucose homeostasis and hence support the definition of more tailored interventions for the treatment of type 2 diabetes.

[1]  P. Neufer,et al.  Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Aurelio Cappozzo,et al.  A mathematical model of interleukin-6 dynamics during exercise , 2015 .

[3]  M. Febbraio,et al.  Muscle-derived interleukin-6—A possible link between skeletal muscle, adipose tissue, liver, and brain , 2005, Brain, Behavior, and Immunity.

[4]  Deepak Kumar.  A Mathematical Model on Glucose-Insulin Regulatory System with the Impact of Physical Activities , 2016 .

[5]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[6]  Mats O Karlsson,et al.  An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Healthy Volunteers , 2010, Journal of clinical pharmacology.

[7]  D. Cunningham,et al.  A Comparison of Modelling Techniques used to Characterise Oxygen Uptake Kinetics During the on‐Transient of Exercise , 2001, Experimental physiology.

[8]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[9]  A. Tura,et al.  Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic , 2014, Diabetologia.

[10]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[11]  B. Saltin,et al.  Interleukin‐6 production in contracting human skeletal muscle is influenced by pre‐exercise muscle glycogen content , 2001, The Journal of physiology.

[12]  B. Saltin,et al.  Searching for the exercise factor: is IL-6 a candidate? , 2004, Journal of Muscle Research & Cell Motility.

[13]  M. Febbraio,et al.  IL-6 muscles in on the gut and pancreas to enhance insulin secretion. , 2012, Cell metabolism.

[14]  J. Bülow,et al.  Interleukin‐6 production in human subcutaneous abdominal adipose tissue: the effect of exercise , 2002, The Journal of physiology.

[15]  D. Drucker,et al.  Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.

[16]  D. James,et al.  Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase , 2006, Diabetes.

[17]  Alessandro Bertuzzi,et al.  Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. , 2011, American journal of physiology. Endocrinology and metabolism.

[18]  Claudio Cobelli,et al.  A model of GLP-1 action on insulin secretion in nondiabetic subjects. , 2010, American journal of physiology. Endocrinology and metabolism.

[19]  A. Steensberg,et al.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[20]  J. Meier.  GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus , 2012, Nature Reviews Endocrinology.

[21]  C Bogardus,et al.  Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. , 2001, Obesity research.

[22]  S. Kahn,et al.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future , 2014, The Lancet.

[23]  C. Cobelli,et al.  Physical Activity into the Meal Glucose—Insulin Model of Type 1 Diabetes: In Silico Studies , 2009, Journal of diabetes science and technology.

[24]  Elan L. Ohayon,et al.  A Mathematical Model of the Oral Glucose Tolerance Test Illustrating the Effects of the Incretins , 2007, Annals of Biomedical Engineering.

[25]  D. Svitra,et al.  Modelling of glycaemia dynamics: impact of physical exercises , 2010 .

[26]  A. Boutayeb,et al.  The effect of physical exercise on the dynamics of glucose and insulin. , 2002, Journal of biomechanics.

[27]  R. Parker,et al.  Dynamic Modeling of Exercise Effects on Plasma Glucose and Insulin Levels , 2007, Journal of diabetes science and technology.

[28]  G. Saidel,et al.  Multi-Scale Computational Model of Fuel Homeostasis During Exercise: Effect of Hormonal Control , 2006, Annals of Biomedical Engineering.

[29]  Ewart R. Carson,et al.  The mathematical modeling of metabolic and endocrine systems : model formulation, identification, and validation , 1983 .

[30]  B. Pedersen,et al.  A trauma‐like elevation of plasma cytokines in humans in response to treadmill running , 1998, The Journal of physiology.

[31]  H. Kuipers,et al.  The Relation Between Power Output, Oxygen Uptake and Heart Rate in Male Athletes , 1994, International journal of sports medicine.

[32]  Micaela Morettini,et al.  Mathematical model of standard oral glucose tolerance test for characterization of insulin potentiation in health , 2012 .

[33]  M. Gassmann,et al.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells , 2011, Nature Medicine.

[34]  B. Pedersen,et al.  Supplementation with vitamins C and E inhibits the release of interleukin‐6 from contracting human skeletal muscle , 2004, The Journal of physiology.

[35]  Bente Klarlund Pedersen,et al.  Physical activity and plasma interleukin-6 in humans – effect of intensity of exercise , 2000, European Journal of Applied Physiology.

[36]  A. Steensberg,et al.  Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model , 2011, European Journal of Applied Physiology.

[37]  MATHEMATICAL MODEL FOR THE DYNAMICS OF GLUCOSE REGULATORY SYSTEM UNDER THE COMBINED USE OF DIETING AND PHYSICAL ACTIVITY , 2012 .

[38]  I. Adamu,et al.  Mathematical Model for the Dynamics of Glucose Regulatory System under the Combined Effect of Dieting and Physical Activity , 2014 .

[39]  M. Nauck,et al.  Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors , 2016, Diabetes, obesity & metabolism.

[40]  A. Hill,et al.  Muscular Exercise, Lactic Acid, and the Supply and Utilization of Oxygen , .

[41]  J. Bülow,et al.  Metabolic effects of interleukin‐6 in human splanchnic and adipose tissue , 2002, The Journal of physiology.

[42]  B. Saltin,et al.  Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6 , 2000, The Journal of physiology.

[43]  P. Felig,et al.  Fuel homeostasis in exercise. , 1975, The New England journal of medicine.

[44]  Haiming Cao.  Adipocytokines in obesity and metabolic disease. , 2014, The Journal of endocrinology.

[45]  M. Febbraio,et al.  Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. , 2005, American journal of physiology. Endocrinology and metabolism.

[46]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[47]  N. Bishop,et al.  Arm and Intensity-Matched Leg Exercise Induce Similar Inflammatory Responses. , 2016, Medicine and science in sports and exercise.

[48]  Aurelio Cappozzo,et al.  Effects of walking on low-grade inflammation and their implications for Type 2 Diabetes , 2015, Preventive medicine reports.

[49]  N. Secher,et al.  Hepatosplanchnic clearance of interleukin-6 in humans during exercise. , 2003, American journal of physiology. Endocrinology and metabolism.

[50]  M. Febbraio,et al.  Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.